FAES Farma SA operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares FAES Farma SA with three other
pharmaceutical manufacturers in Europe:
sales of 191.99 million Euro [US$225.88 million]
of which 68%
was Pharmaceutical Synthesis),
Vectura Group PLC
of the United Kingdom
(£168.25 million [US$225.23 million]
of which 100%
was Pharmaceutical Prod), and
Dechra Pharmaceuticals PLC
based in the United Kingdom
(£247.56 million [US$331.41 million]
of which 76%
was European Pharmaceuticals).
FAES Farma SA reported sales of 228.64 million Euro (US$268.98 million)
December of 2016.
increase of 11.7%
versus 2015, when the company's sales were 204.72 million Euro.
This was the fourth straight year of sales growth at FAES Farma SA.
Sales of Specialty Pharmaceuticals saw an increase
14.2% in 2016, from
174.19 million Euro to 198.95 million Euro.
Not all segments of FAES Farma SA experienced an increase in sales in 2016:
sales of Other fell 2.8% to 29.69 million Euro.